The finance minister’s budget includes a big boost in spending on reducing malnutrition, clearly the priority among the social services programs of the Congress party-led government. Finance Minister Pranab Mukherjee said India will increase spending on malnutrition programs by 58% in fiscal 2012-13 to 158 billion rupees, or about $3 billion. Included in this new spending is a plan to reorganize the Integrated Child Development Services, the central government-led initiative that has...
More »SEARCH RESULT
Polio blow in Bengal with vaccine lesson-GS Mudur
India has recorded its first case of polio caused by a vaccine-derived poliovirus (VDPV) this year in a five-month-old child in Murshidabad district of Bengal but the country remains free of the wild poliovirus. A polio surveillance laboratory in Calcutta has found that the child from Lalbag block in Murshidabad was infected by VDPV, which occurs when the weakened virus in the oral polio vaccine (OPV) mutates over time, and regains...
More »India to be a youngest nation by 2020 by Aarti Dhar
India will be one of the youngest nations by 2020 and this changing demographic condition, while providing great opportunities, could pose some challenges too, the Economic Survey 2011-12 has said. India is passing through a phase of unprecedented demographic changes, wherein the proportion of the working age population (15-59 years) is likely to rise from around 58 per cent in 2001 to over 64 per cent by 2021, according to the...
More »Why this will be a reform budget-Surjit S Bhalla
Most of us don’t even get a single shot at making history — Manmohan Singh has a second chance The fiscal deficit is an outcome, not a policy. It is the net resolution of the policies pertaining to taxes and expenditure. It is worth analysing separately the two components of the deficit. The table reports the results of relating the tax and expenditure share of GDP to per capita income for...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »